315 related articles for article (PubMed ID: 34144044)
1. COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States.
Hadi YB; Thakkar S; Shah-Khan SM; Hutson W; Sarwari A; Singh S
Gastroenterology; 2021 Oct; 161(4):1336-1339.e3. PubMed ID: 34144044
[No Abstract] [Full Text] [Related]
2. Methotrexate for inflammatory bowel disease: time for reconsideration.
Nielsen OH; Ainsworth MA; Steenholdt C
Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):407-409. PubMed ID: 30895827
[No Abstract] [Full Text] [Related]
3. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
Renna S; Cottone M; Orlando A
World J Gastroenterol; 2014 Aug; 20(29):9675-90. PubMed ID: 25110407
[TBL] [Abstract][Full Text] [Related]
4. Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
Korelitz BI
World J Gastroenterol; 2013 May; 19(20):2979-84. PubMed ID: 23716977
[TBL] [Abstract][Full Text] [Related]
5. Preventing infective complications in inflammatory bowel disease.
Mill J; Lawrance IC
World J Gastroenterol; 2014 Aug; 20(29):9691-8. PubMed ID: 25110408
[TBL] [Abstract][Full Text] [Related]
6. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
[TBL] [Abstract][Full Text] [Related]
7. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Hanauer SB; Sandborn WJ; Lichtenstein GR
Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
[TBL] [Abstract][Full Text] [Related]
8. Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
Kappelman MD; Weaver KN; Boccieri M; Firestine A; Zhang X; Long MD;
Gastroenterology; 2021 Oct; 161(4):1340-1343.e2. PubMed ID: 34144046
[No Abstract] [Full Text] [Related]
9. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):443-447. PubMed ID: 33522752
[TBL] [Abstract][Full Text] [Related]
10. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
[TBL] [Abstract][Full Text] [Related]
11. Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.
Androulakis I; Zavos C; Christopoulos P; Mastorakos G; Gazouli M
World J Gastroenterol; 2015 Dec; 21(47):13205-11. PubMed ID: 26715803
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence.
Hissong E; Chen Z; Yantiss RK
Mod Pathol; 2019 Jul; 32(8):1210-1216. PubMed ID: 30952971
[TBL] [Abstract][Full Text] [Related]
13. Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?
Narula N; Yamamura DL; Marshall JK
Can J Gastroenterol; 2010 Feb; 24(2):121-5. PubMed ID: 20151071
[TBL] [Abstract][Full Text] [Related]
14. Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.
Quetglas EG; Armuzzi A; Wigge S; Fiorino G; Barnscheid L; Froelich M; Danese S
Eur J Clin Pharmacol; 2015 Jul; 71(7):773-99. PubMed ID: 26008212
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
Bossa F; Carparelli S; Latiano A; Palmieri O; Tavano F; Panza A; Pastore M; Marseglia A; D'Altilia M; Latiano T; Corritore G; Martino G; Nardella M; Guerra M; Terracciano F; Sacco M; Perri F; Andriulli A
Dig Liver Dis; 2021 Mar; 53(3):277-282. PubMed ID: 33423942
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group.
Arrigo S; Alvisi P; Banzato C; Bramuzzo M; Celano R; Civitelli F; D'Arcangelo G; Dilillo A; Dipasquale V; Felici E; Fuoti M; Gatti S; Knafelz D; Lionetti P; Mario F; Marseglia A; Martelossi S; Moretti C; Norsa L; Panceri R; Renzo S; Romano C; Romeo E; Strisciuglio C; Martinelli M
Dig Liver Dis; 2021 Mar; 53(3):283-288. PubMed ID: 33388247
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.
Ochsenkühn T; Tillack C; Szokodi D; Janelidze S; Schnitzler F
United European Gastroenterol J; 2020 Feb; 8(1):91-98. PubMed ID: 32213052
[TBL] [Abstract][Full Text] [Related]
19. Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy.
Sartini A; Scaioli E; Liverani E; Bellanova M; Ricciardiello L; Bazzoli F; Belluzzi A
Dig Dis Sci; 2019 Mar; 64(3):863-874. PubMed ID: 30334112
[TBL] [Abstract][Full Text] [Related]
20. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.
Borman ZA; Côté-Daigneault J; Colombel JF
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1101-1108. PubMed ID: 30277409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]